Rita T. Pereira

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

Journal: Journal of medical virology

Published: March 30, 2026

Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging.

Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging.

Journal: Neuro-oncology advances

Published: September 09, 2025

Pushing the envelope - How the genome interacts with the nuclear envelope in health and disease.

Pushing the envelope - How the genome interacts with the nuclear envelope in health and disease.

Journal: Advances in protein chemistry and structural biology

Published: January 22, 2025

An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene.

An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene.

Journal: Acta neuropathologica communications

Published: August 01, 2024

Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.

Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.

Journal: Microbiology spectrum

Published: June 25, 2024

The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations.

The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 19, 2024

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.

Journal: Cancer cell

Published: April 12, 2024

Alterations to Genome Organisation in Stem Cells, Their Differentiation and Associated Diseases.

Alterations to Genome Organisation in Stem Cells, Their Differentiation and Associated Diseases.

Journal: Results and problems in cell differentiation

Published: November 08, 2022

Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.

Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.

Journal: Cancer cell

Published: April 12, 2022

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.

Journal: Journal for immunotherapy of cancer

Published: March 15, 2022

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

Journal: Molecular cancer

Published: October 20, 2021

HER3 Is an Actionable Target in Advanced Prostate Cancer.

HER3 Is an Actionable Target in Advanced Prostate Cancer.

Journal: Cancer research

Published: October 04, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026